Medifast Reports Mixed Results, Joins Coursera, Chegg And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Medifast Reports Mixed Results, Joins Coursera, Chegg And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
U.S. stock futures were slightly lower this morning, with the Nasdaq futures falling around 0.1% on Tuesday.
今天上午美国股票期货小幅走低，纳斯达克期货周二下跌约0.1％。
Shares of Medifast, Inc. (NYSE:MED) fell sharply in today's pre-market trading after the company reported mixed first-quarter financial results.
Medifast, Inc.（纽约证券交易所代码：MED）的股价在今天的盘前交易中大幅下跌，此前该公司公布的第一季度财务业绩喜忧参半。
Medifast posted adjusted earnings of 66 cents per share, missing market estimates of 78 cents per share. The company's quarterly sales came in at $174.739 million versus expectations of $168.900 million, according to data from Benzinga Pro.
Medifast公布的调整后每股收益为66美分，未达到市场预期的每股78美分。根据Benzinga Pro的数据，该公司的季度销售额为1.74739亿美元，而预期的为1.689亿美元。
Medifast shares tumbled 15.6% to $29.95 in pre-market trading.
在盘前交易中，Medifast股价下跌15.6％，至29.95美元。
Here are some big stocks recording losses in today's pre-market trading session.
以下是一些在今天的盘前交易时段中录得亏损的大型股票。
- Coursera, Inc. (NYSE:COUR) shares dipped 12.7% to $10.37 in pre-market trading after the company reported mixed first-quarter financial results and issued FY24 revenue guidance below estimates.
- Chegg, Inc. (NYSE:CHGG) shares declined 12.1% to $6.30 in pre-market trading after the company posted first-quarter results and named Nathan Shultz as CEO.
- ADC Therapeutics SA (NASDAQ:ADCT) fell 6.7% to $4.20 in pre-market trading. The company, earlier during the month, announced the completion of dose escalation in LOTIS-7, a Phase 1b open-label clinical trial evaluating ZYNLONTA in combination with glofitamab or mosunetuzumab in heavily pre-treated patients with relapsed/refractory B-cell non-Hodgkin lymphoma.
- Mesoblast Ltd (NASDAQ:MESO) shares declined 5.7% to $6.69 in pre-market trading.
- Coeur Mining, Inc. (NYSE:CDE) shares fell 5.7% to $4.63 in pre-market trading.
- Prudential plc (NYSE:PUK) slipped 5.1% to $17.84 in pre-market trading. Prudential, last month, reported worse-than-expected FY 2023 revenues and earnings.
- Yum China Holdings, Inc. (NYSE:YUMC) shares declined 5.1% to $38.00 in pre-market trading. Yum China posted upbeat earnings for its first quarter, while sales missed expectations.
- Sibanye Stillwater Limited (NYSE:SBSW) shares fell 5% to $4.82 in pre-market trading.
- Rambus Inc. (NASDAQ:RMBS) shares declined 4.1% to $58.01 in pre-market trading following first-quarter results.
- Coursera, Inc.（纽约证券交易所代码：COUR）股价在盘前交易中下跌12.7％，至10.37美元，此前该公司公布的第一季度财务业绩喜忧参半，发布的24财年收入指引低于预期。
- Chegg, Inc.（纽约证券交易所代码：CHGG）股价在盘前交易中下跌12.1％，至6.30美元，此前该公司公布了第一季度业绩并任命内森·舒尔茨为首席执行官。
- ADC Therapeutics SA（纳斯达克股票代码：ADCT）在盘前交易中下跌6.7％，至4.20美元。该公司在本月早些时候宣布，LOTIS-7 的剂量递增已完成，这是一项1b期开放标签临床试验，评估ZYNLONTA与glofitamab或mosunetuzumab联合治疗的复发/难治性B细胞非霍奇金淋巴瘤患者。
- Mesoblast Ltd（纳斯达克股票代码：MESO）股价在盘前交易中下跌5.7％，至6.69美元。
- 科尔矿业公司（纽约证券交易所代码：CDE）股价在盘前交易中下跌5.7％，至4.63美元。
- 保诚集团（纽约证券交易所代码：PUK）在盘前交易中下跌5.1％，至17.84美元。保诚上个月公布的2023财年收入和收益低于预期。
- 百胜中国控股有限公司（纽约证券交易所代码：YUMC）股价在盘前交易中下跌5.1％，至38.00美元。百胜中国公布了乐观的第一季度收益，而销售额未达到预期。
- Sibanye Stillwater Limited（纽约证券交易所代码：SBSW）股价在盘前交易中下跌5％，至4.82美元。
- 第一季度业绩公布后，兰布斯公司（纳斯达克股票代码：RMBS）股价在盘前交易中下跌4.1％，至58.01美元。
Now Read This: Investor Sentiment Improves Further, Dow Jumps Over 100 Points
立即阅读这篇文章：投资者情绪进一步改善，道琼斯指数上涨超过100点
Don't forget to check out our premarket coverage here
别忘了在这里查看我们的上市前报道